Autophagy in nuclear receptor PPARgamma-deficient mouse prostatic carcinogenesis

Area of Science:

• Molecular biology
• Cell biology
• Oncology

Background:

• Peroxisome proliferator-activated receptor-gamma (PPARgamma) is crucial for lipid metabolism and cell differentiation.
• Prostate carcinogenesis involves altered fatty acid oxidation and oxidative stress.
• The role of autophagy in PPARgamma-mediated prostate cancer development is unclear.

Purpose of the Study:

• To investigate the involvement of autophagy in PPARgamma-deficient mouse prostate epithelial cells.
• To characterize the cellular and molecular changes associated with PPARgamma deficiency during prostatic carcinogenesis.
• To explore the potential of PPARgamma re-expression for rescuing autophagic phenotypes.

Main Methods:

• Utilized in vitro and in vivo models of PPARgamma and PPARgamma2 deficiency in mouse prostate epithelia.
• Employed electron microscopy to examine subcellular structures like lysosomes and autophagic vacuoles.
• Conducted gene expression profiling to analyze metabolic and cell cycle signaling networks.

Main Results:

• PPARgamma deficiency led to altered cellular proliferation, de-differentiation, and prostatic intraepithelial neoplasia (mPIN).
• Accumulation of defective lysosomes and autophagic vacuoles was observed in deficient cells, indicating autophagy.
• Gene expression analysis revealed dysregulation in cell cycle control and metabolic pathways, including lipid oxidation and organelle maturation.
• Re-expression of PPARgamma1 or PPARgamma2 isoforms rescued the autophagic phenotypes in PPARgamma-null cells.

Conclusions:

• Autophagy is implicated in the pathogenesis of PPARgamma-deficient murine prostatic intraepithelial neoplasia.
• PPARgamma plays a significant role in regulating autophagy, lipid metabolism, and cellular differentiation in prostate epithelium.
• Targeting PPARgamma may offer therapeutic strategies for prostate cancer by modulating autophagy and related cellular processes.